Dolutegravir

Overview

Categories

Primary Characterstics

Indications

Back to top

Pharmacokinetics

Back to top

Contraindications

Back to top

Drug Interactions

Back to top

Side Effects

Back to top

Dosage

Dolutegravir's dosage details are as follows:
Dose Single Dose Frequency Route Instructions

Adult Dosage

0 to 50 mg25 (25)As recommended.POPatients infected with HIV-1 without suspected resistance to the integrase class
50 mg50 (50)As recommended.POpatient infected with HIV-1 without suspected resistance to the integrase classwhen co-administered with some medicines (e.g. efavirenz, nevirapine, tipranavir/ritonavir, or rifampicin) i
50 mg50 (50)As recommended.POPatients infected with HIV-1 with resistance to the integrase class

Paedriatic Dosage (20kg)

0 to 50 mg25 (25)As recommended.POpediatric patients aged 12 years and older and weighing at least 40 kg

Neonatal Dosage (3kg)

No data regarding the neonatal dosage details of Dolutegravir is available.

High Risk Groups

Back to top

Warning / Precautions

Back to top

Storage Conditions

Back to top

Interference in Pathology

Back to top

Brands / Trade Names of Dolutegravir

Back to top

Manufacturers of Dolutegravir in Pakistan

Back to top

Previous Drug Generic - Next Drug Generic